STOCK TITAN

Astera Labs (ALAB) director logs 12,499-share Rule 10b5-1 sale

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Astera Labs director Stefan A. Dyckerhoff reported open-market sales totaling 12,499 shares of Common Stock on May 7, 2026. The shares were sold at weighted-average prices of $201.102 and $199.00 per share under a Rule 10b5-1 trading plan adopted on December 1, 2025.

After these sales, Dyckerhoff holds 65,361 shares directly and additional indirect positions, including 332,160 shares held by a trust and 6,278 shares held by a limited partnership, where he disclaims beneficial ownership except for his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Dyckerhoff Stefan A
Role null
Sold 12,499 shs ($2.50M)
Type Security Shares Price Value
Sale Common Stock 1,783 $199.00 $355K
Sale Common Stock 4,238 $199.00 $843K
Sale Common Stock 336 $199.00 $67K
Sale Common Stock 1,722 $201.102 $346K
Sale Common Stock 4,095 $201.102 $824K
Sale Common Stock 325 $201.102 $65K
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 65,361 shares (Direct, null); Common Stock — 332,160 shares (Indirect, By Trust)
Footnotes (1)
  1. Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.00 to $201.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held by an irrevocable trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.
Shares sold 12,499 shares Total net shares sold on May 7, 2026
Sale price (first block) $201.102 per share Weighted-average price for certain May 7, 2026 sales
Sale price (second block) $199.00 per share Price for additional May 7, 2026 sales
Direct holdings after sale 65,361 shares Common Stock held directly after May 7, 2026 transactions
Trust holdings after sale 332,160 shares Common Stock held indirectly by a trust after transactions
Limited partnership holdings 6,278 shares Common Stock held indirectly by a limited partnership after transactions
Price range disclosure $201.00–$201.40 Range of prices for trades in weighted-average block
Rule 10b5-1 trading plan financial
"Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
limited partnership financial
"Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner."
A limited partnership is a legal business structure with two types of partners: at least one general partner who runs the business and bears full legal responsibility, and one or more limited partners who contribute money, share profits, and have liability capped at their investment. For investors, it matters because it separates control from financial exposure — like putting money into a store without managing it — and affects how returns, risks, taxes and transferability of ownership are handled.
irrevocable trust financial
"Shares held by an irrevocable trust of which the Reporting Person is a Trustee."
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
pecuniary interest financial
"The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dyckerhoff Stefan A

(Last)(First)(Middle)
755 PAGE MILL ROAD, SUITE A-200

(Street)
PALO ALTO CALIFORNIA 94304-1005

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Astera Labs, Inc. [ ALAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/07/2026S(1)1,783D$19965,361D
Common Stock05/07/2026S(1)4,238D$199332,160IBy Trust(2)
Common Stock05/07/2026S(1)336D$1996,278IBy Limited Partnership (TF)(3)
Common Stock05/07/2026S(1)1,722D$201.102(4)63,639D
Common Stock05/07/2026S(1)4,095D$201.102(4)328,065IBy Trust(2)
Common Stock05/07/2026S(1)325D$201.102(4)5,953IBy Limited Partnership (TF)(3)
Common Stock3,767IBy DIFT-2(5)
Common Stock3,765IBy DIFT-AMD(5)
Common Stock3,765IBy DIFT-BAD(5)
Common Stock3,765IBy DIFT-SHD(5)
Common Stock3,765IBy DIFT-IND(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025.
2. Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.
3. Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.00 to $201.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. Shares held by an irrevocable trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.
/s/ Kanwalpreet S. Kalra, Attorney-in-Fact05/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Astera Labs (ALAB) director Stefan Dyckerhoff report in this Form 4?

Director Stefan A. Dyckerhoff reported open-market sales of 12,499 Astera Labs shares on May 7, 2026. These transactions were executed at weighted-average prices around $201.10 and $199.00 per share under a pre-established Rule 10b5-1 trading plan.

How many Astera Labs (ALAB) shares did Stefan Dyckerhoff sell and at what prices?

Stefan Dyckerhoff sold 12,499 shares of Astera Labs Common Stock. Portions of the sale occurred at a weighted-average price of $201.102 and other portions at $199.00 per share, with one price range disclosed between $201.00 and $201.40 per share.

Were Stefan Dyckerhoff’s Astera Labs (ALAB) share sales made under a Rule 10b5-1 plan?

Yes. The filing states that the shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Stefan Dyckerhoff on December 1, 2025. Such plans pre-schedule trades, helping separate trading activity from short-term market information.

How many Astera Labs (ALAB) shares does Stefan Dyckerhoff hold after these transactions?

Following the reported sales, Stefan Dyckerhoff holds 65,361 Astera Labs shares directly. He also has indirect holdings, including 332,160 shares through a trust and 6,278 shares through a limited partnership, with beneficial ownership disclaimed except for his pecuniary interest.

What does it mean that some Astera Labs (ALAB) shares are held by trusts and partnerships?

Several positions are held through trusts and a limited partnership. The filing explains that these entities hold the shares, and Stefan Dyckerhoff disclaims beneficial ownership of those shares except for his pecuniary interest, clarifying that control and economic benefits may differ.

How large was the net selling activity in this Astera Labs (ALAB) Form 4?

The transaction summary shows a net sale of 12,499 shares, with six sale transactions and no reported purchases or option exercises. This results in a net-sell direction for the period covered by the Form 4, based solely on the disclosed trades.